Literature DB >> 2551051

Walking and cycling tests in neurogenic and intermittent claudication.

G Dong1, R W Porter.   

Abstract

The walking and cycling tolerance of 19 patients with neurogenic claudication and 11 with intermittent claudication was assessed, first in the upright and then in 30 degrees of flexion, repeating the tests on a second day. The flexed posture improved the walking and cycling distance, respectively, in 11 and six patients with neurogenic claudication. In two of the 11 patients, this posture significantly improved by more than 100% of both walking and cycling distances. In addition, one patient had claudication pain when he was walking, but could cycle unlimited distance. Only one of the patients with intermittent claudication could walk or cycle further in the flexed position. Although some patients with neurogenic claudication increase their walking distance by flexing forwards, we conclude that posture-related walking and cycling are insufficiently sensitive tests to distinguish between neurogenic and intermittent claudication.

Entities:  

Mesh:

Year:  1989        PMID: 2551051     DOI: 10.1097/00007632-198909000-00009

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  15 in total

1.  Spinal claudication versus arterial claudication.

Authors:  M Maher; D J Hehir; P Neary; J Hinchion; J A O'Donnell
Journal:  Ir J Med Sci       Date:  1996 Apr-Jun       Impact factor: 1.568

2.  Lumbar spinal canal stenosis-special features.

Authors:  P Gopinathan
Journal:  J Orthop       Date:  2015-06-16

3.  Loading is more effective than posture in lumbar spinal stenosis: a study with a treadmill equipment.

Authors:  Hasan Oğuz; Funda Levendoğlu; Tunç Cevat Oğün; Aysenur Tantuğ
Journal:  Eur Spine J       Date:  2007-02-02       Impact factor: 3.134

4.  Comparison between walking test and treadmill test for intermittent claudication associated with lumbar spinal canal stenosis.

Authors:  Shinji Tanishima; Satoru Fukada; Hiroyuki Ishii; Toshiyuki Dokai; Yasuo Morio; Hideki Nagashima
Journal:  Eur Spine J       Date:  2014-08-14       Impact factor: 3.134

5.  Quantification of walking ability in subjects with neurogenic claudication from lumbar spinal stenosis--a comparative study.

Authors:  James Rainville; Lisa A Childs; Enrique B Peña; Pradeep Suri; Janet C Limke; Cristin Jouve; David J Hunter
Journal:  Spine J       Date:  2011-12-29       Impact factor: 4.166

6.  Postoperative rehabilitation does not improve functional outcome in lumbar spinal stenosis: a prospective study with 2-year postoperative follow-up.

Authors:  Timo J Aalto; Ville Leinonen; Arto Herno; Markku Alen; Heikki Kröger; Veli Turunen; Sakari Savolainen; Tapani Saari; Olavi Airaksinen
Journal:  Eur Spine J       Date:  2011-04-27       Impact factor: 3.134

7.  A prospective randomized multi-center study for the treatment of lumbar spinal stenosis with the X STOP interspinous implant: 1-year results.

Authors:  J F Zucherman; K Y Hsu; C A Hartjen; T F Mehalic; D A Implicito; M J Martin; D R Johnson; G A Skidmore; P P Vessa; J W Dwyer; S Puccio; J C Cauthen; R M Ozuna
Journal:  Eur Spine J       Date:  2003-12-19       Impact factor: 3.134

8.  Tandem spinal stenosis: a case of stenotic cauda equina syndrome following cervical decompression and fusion for spondylotic cervical myelopathy.

Authors:  Brian T Swanson
Journal:  J Man Manip Ther       Date:  2012-02

9.  Assessment and management of neurogenic claudication associated with lumbar spinal stenosis in a UK primary care musculoskeletal service: a survey of current practice among physiotherapists.

Authors:  Christine M Comer; Anthony C Redmond; Howard A Bird; Philip G Conaghan
Journal:  BMC Musculoskelet Disord       Date:  2009-10-01       Impact factor: 2.362

10.  High failure rate of the interspinous distraction device (X-Stop) for the treatment of lumbar spinal stenosis caused by degenerative spondylolisthesis.

Authors:  Olaf J Verhoof; Johannes L Bron; Frits H Wapstra; Barend J van Royen
Journal:  Eur Spine J       Date:  2007-09-11       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.